Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BGNE will rise by +41.13% over the next 2 Weeks and hit $260.68 by Wednesday, February 12, 2025. In that time frame, BGNE's share price is expected to range between $251.95 and $269.75.
BearishAverageBullishBGNE shares rose +0.49% in Tuesday, December 31, 2024's trading session, rising from a previous close of $183.81 to move at $184.71. The stock demonstrated notable intraday movement (see BGNE's key stats for a full breakdown), fluctuating between $183.91 and $187.42, a +1.91% trading range. While recent weeks have seen some volatility, BGNE has managed to secure a -8.43% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 111.11K shares changing hands, 98.99K fewer than the previous session. This amounted to $20.52M in total market activity.
Will BGNE Continue Its Upward Trend?
According to analyst ratings and projections for BGNE, BeiGene, Ltd. shares are anticipated to increase by +31.26%, potentially reaching $268.71 per share by February 12, 2025. Short-term technical indicators for BGNE currently suggest a bullish sentiment. This aligns with the stock's recent performance, as it has recorded 19 positive trading days within the past 30 sessions. Based on the BGNE stock forecast, now is a good time to buy BGNE stock because its current trading price is -28.80% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on BGNE covering social and institutional perspectives.
BGNE Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BGNE's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 44.66% to 48.70%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 47.54%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 49.51%, maintains a neutral outlook for the long term. Insights into BGNE's shareholder base show how institutional investors are positioning themselves during these momentum shifts
BeiGene Short-Term Forecasts
BGNE Forecast For Next 5 Days
Our algorithm anticipates BeiGene (BGNE) stock could hit $152.19 by Jan 24, 2025. This represents a -17.61% rise from today's price, following a +3.94% change over the past five days.
BGNE Forecast For Next 30 Days
Based on analysis of market trends, the outlook for BeiGene, Ltd. (BGNE) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $154.85, which would mean a -16.17% decrease from the current price of $184.71. Projections for this period range from a high of $169.25 to a low of $137.52.
BGNE Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for BeiGene's price over the next three months point to a drop. BGNE stock is expected to peak at $223.79 on Nov 11, 2025 after potentially dipping to $123.87 on Oct 13, 2025. On average, BGNE is likely to trade around $158.83 in the coming 90 days.
BeiGene Stock Forecast 2025
Based on our predictive models, BeiGene (BGNE) is expected to trade between $123.87 and $223.79 throughout 2025. This would result in an average price of $162.43, potentially offering investors a -12.06% return from current levels.
BeiGene, Ltd. Monthly Forecast 2025–2026
January 2025
According to our latest forecast models, BeiGene, Ltd. (BGNE) is positioned to show a strong performance in January 2025. The price is predicted to move between $143.78 and $188.38, settling at an average of $166.56. This could translate to a -9.83% loss.
February 2025
Based on current market signals, BeiGene, Ltd. is projected to trend february 2025. We forecast a trading range from $148.35 to $207.22, with a likely average price of $178.85. Investors could expect a potential return of -3.17%.
March 2025
Our predictive algorithms indicate BeiGene, Ltd. stock may see a shift in March 2025. The expected range spans $140.43–$204.36, with an average target of $170.87. This represents a cautious outlook and a possible loss of -7.49%.
April 2025
Analyzing established trends, BeiGene, Ltd. looks set to move in April 2025. Projections place the stock between $133.94 and $177.94, averaging around $155.98. This suggests a -15.55% loss from current levels.
May 2025
Market indicators suggest BeiGene, Ltd. could experience notable changes during May 2025. Prices could fluctuate within $139.51 to $182.09, with a midpoint forecast of $160.96. The stock might deliver a -12.86% loss.
June 2025
Forecasting for June 2025, models estimate that BeiGene, Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $138.85 and $181.71, averaging $160.03. This signals a cautious trajectory with potential returns around -13.36%.
July 2025
According to our latest forecast models, BeiGene, Ltd. (BGNE) is positioned to show a strong performance in July 2025. The price is predicted to move between $142.38 and $197.66, settling at an average of $172.01. This could translate to a -6.88% loss.
August 2025
Based on current market signals, BeiGene, Ltd. is projected to trend august 2025. We forecast a trading range from $131.92 to $192.22, with a likely average price of $161.53. Investors could expect a potential return of -12.55%.
September 2025
Our predictive algorithms indicate BeiGene, Ltd. stock may see a shift in September 2025. The expected range spans $128.11–$174.45, with an average target of $149.37. This represents a cautious outlook and a possible loss of -19.13%.
October 2025
Analyzing established trends, BeiGene, Ltd. looks set to move in October 2025. Projections place the stock between $123.87 and $173.75, averaging around $153.54. This suggests a -16.88% loss from current levels.
November 2025
Market indicators suggest BeiGene, Ltd. could experience notable changes during November 2025. Prices could fluctuate within $129.29 to $223.79, with a midpoint forecast of $156.03. The stock might deliver a -15.53% loss.
December 2025
Forecasting for December 2025, models estimate that BeiGene, Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $136.80 and $190.60, averaging $166.20. This signals a cautious trajectory with potential returns around -10.02%.
January 2026
According to our latest forecast models, BeiGene, Ltd. (BGNE) is positioned to show a strong performance in January 2026. The price is predicted to move between $141.09 and $178.25, settling at an average of $159.02. This could translate to a -13.91% loss.
BGNE's history of dividends and stock splits also plays a role in long-term investor confidence.